SU
SAURABH UPADHYAY
Columbia University in the City of New York, Springer Nature (United Kingdom), Indian Institute of Technology Delhi, Jamia Millia Islamia, Weill Cornell Medicine, University of Delhi
0000-0001-9394-7321
Employment
-
Columbia University in the City of New York Postdoctoral Research Scientist2026 - Present
-
Springer Nature (United Kingdom) Associate Editor2026 - Present
-
Weill Cornell Medicine Postdoctoral Associate2025 - 2026
-
St. Jude children research hospital Post doctoral research associate2023 - 2024
-
Indian Institute of Technology Delhi PhD2018 - 2023
Education
-
Indian Institute of Technology Delhi PhD2018 - 2023
-
Jamia Millia Islamia M.Sc2015 - 2017
-
University of Delhi B.Sc hons.2011 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (26)
- Innate immune sensors of inflammasomes and PANoptosomes: structural–mechanistic insights and therapeutic implications Save
- CAR T cell therapy beyond cancer: current status, challenges and future prospects Save
- AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 Binders Save
- AI-Designed Cyclic Peptides Enable Controllable Modulation of the CD28 Immune Checkpoint. Save
- PANoptosis as a drug discovery framework: integrating cell death architecture with clinical translation Save
- Overcoming the undruggable barrier: Structure-guided discovery of a potent small molecule CD28 antagonist with translational potential Save
- Cyclin-dependent kinases as signaling integrators in cancer: Structural evolution, functional plasticity, and drug discovery Save
- An Optimized Enzyme-Coupled Spectrophotometric Method for Measuring Pyruvate Kinase Kinetics Save
- Wiring and rewiring PANoptosis: Molecular vulnerabilities for targeting inflammatory cell death in human disease Save
- Structure-based virtual screening identifies potent CD28 inhibitors that suppress T cell co-stimulation in cellular and mucosal models Save